Noven Recalls Estradiol Transdermal Patches Due to Adhesive Defects
Noven Pharmaceuticals is recalling Estradiol Transdermal Systems because the adhesive may not stick well to the skin.
- Product
- ESTRADIOL (ESTRADIOL)
- Category
- Distribution
- 0 states
FDA (Drugs) recall action 87741
The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.
Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Noven Pharmaceuticals is recalling Estradiol Transdermal Systems because the adhesive may not stick well to the skin.
Noven Pharmaceuticals is recalling Minivelle estradiol transdermal patches because the adhesive may not stick well to the skin.